Reading Level: Easy Read

Question of the Month #13: How Can Thymic Regeneration Combat Age-Related Autoimmunity? Part of Michael Rae’s regular column from the Foundation’s newsletter.

Question of the Month #12: Energy-Carrying Molecules to Boost Aging Mitochondria? Part of Michael Rae’s regular column from the Foundation’s newsletter.

Question of the Month #10: Rejuvenation for calcification amelioration? Part of Michael Rae’s regular column from the Foundation’s newsletter.

Question of the Month #9: What is the role of novel diagnostics in rejuvenation biotechnologies? Part of Michael Rae’s regular column from the Foundation’s newsletter.

Question of the Month #8: Aging Damage and Early Early Detection. Part of Michael Rae’s regular column from the Foundation’s newsletter.

The genomic revolution stands poised to transform cancer therapy and many areas of medicine. SENS Research Foundation-funded researchers outline what needs to be done to take raw results and integrate them into reliable clinical practice.

We’ve all heard the terminology. “Age-related disease.” “The diseases of aging.” “The diseases of old age.” But what do we mean by them? What is the connection between aging and heart disease, or cancer, or Alzheimer’s? And how is SENS Research Foundation targeting that connection to prevent and cure these diseases?

SENS Research Foundation has established a new research center at Cambridge University and a collaboration with scientists at Yale University. The mission: develop new therapies to repair a critical form of molecular damage that drives the slow stiffening of the arteries with age. Such rejuvenation biotechnologies could prevent such deadly and disabling diseases of aging as stroke and kidney disease.

The fifth biannual Strategies for Engineered Negligible Senescence biomedical conference is just days away. Getting ready for the trip has cast my mind back not only to previous meetings of this exciting interdisciplinary series, and also to the recent 40th meeting of the American Aging Association (AGE). AGE was the first, and remains the premier, professional scientific organization focused specifically on biomedical research in aging.

Dr. Doris Taylor, the researcher whose team successfully engineered a live, beating rat heart via the technique of decellularisation and reseeding, has announced progress towards repeating the process with human tissue. Press reports based on Dr. Taylor’s presentation at the American College of Cardiology’s 60th Annual Scientific Session indicate that the hearts are growing well and are expected to begin beating within the next few weeks.